• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Prelude Therapeutics Inc (NQ: PRLD )

    1.190 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Prelude Therapeutics Inc

    < Previous 1 2 Next >
    UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    PRLD Stock Earnings: Prelude Therapeutics Misses EPS for Q2 2024
    PRLD stock results show that Prelude Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Wall Street's Top 10 Stock Calls This Week - Saturday, June 22
    What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of June 17-21, 2024. 
    Via Talk Markets
    PRLD Stock Earnings: Prelude Therapeutics Beats EPS for Q1 2024
    PRLD stock results show that Prelude Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Morgan Stanley Downgrades Prelude Therapeutics: Here's What You Need To Know
    Via Benzinga
    The Latest Analyst Ratings for Prelude Therapeutics
    Via Benzinga
    AI Meets Biotech: 3 Top Stocks Transforming Medical Science
    The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Best Buy To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Thursday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      Wednesday's session saw 150 companies set new 52-week lows. 
    Via Benzinga
    Expert Ratings for Prelude Therapeutics
    Via Benzinga
    Analyst Ratings for Prelude Therapeutics
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      Friday's session saw 169 companies set new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      On Monday, 27 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
      Friday's session saw 59 companies set new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
      During Thursday, 56 stocks hit new 52-week lows. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    The 7 Worst Stocks to Buy Now
    With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now. 
    Via InvestorPlace
    Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group. 
    Via Benzinga
    Carvana, Crocs And Other Big Losers From Monday
    U.S. stocks closed lower on Monday, with the Nasdaq dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
    Via Benzinga
    Why This Prelude Therapeutics Analyst Disagrees With 2 Others And Downgraded The Stock
    Shares of Prelude Therapeutics Inc (NASDAQ: PRLD) came under pressure during early trading on Monday. 
    Via Benzinga
    Marten Transport, Silvergate Capital And Some Other Big Stocks Moving Lower On Tuesday
    U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Tuesday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022
      
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
    Upgrades 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    On Thursday, 236 companies hit new 52-week lows. 
    Via Benzinga
    68 Biggest Movers From Yesterday
    Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie... 
    Via Benzinga
    38 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022
    Upgrades For Turquoise Hill Resources Ltd (NYSE:TRQ), BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the... 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.